Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells

This publication has 50 references indexed in Scilit:

• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
  Oncogene, 2003
• Endocrine-responsive breast cancer and strategies for combating resistance
  Nature Reviews Cancer, 2002
• Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
  The Journal of Steroid Biochemistry and Molecular Biology, 2001
• Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes
  European Journal Of Cancer, 2000
• c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry
  Molecular and Cellular Biology, 1998
• Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
  Molecular and Cellular Biology, 1997
• Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2
  Journal of Biological Chemistry, 1997
• Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
  Molecular Endocrinology, 1996
• Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
  The Lancet, 1995
• Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells
  Breast Cancer Research and Treatment, 1994